Ipsos Healthcare has announced the return of Paul O’Meara to its Global Therapy Monitors team. O’Meara becomes Head of Autoimmune Therapy Monitors, a key portfolio within the company’s syndicated services offering. He will deliver this global remit from Ipsos’ New York City Office. O’Meara leaves Insight Health US, where he was Head of Syndicated Services. Prior to this, he spent 7 years with Ipsos Healthcare (formerly Synovate Healthcare) – joining the company in London in 2005 to set up the Global Psoriasis and Global IBD Therapy Monitors, before relocating to New York to promote the Autoimmune Therapy Monitors.